Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Demetri, George D, Prof ; Reichardt, Peter, Prof ; Kang, Yoon-Koo, Prof ; Blay, Jean-Yves, Prof ; Rutkowski, Piotr, MD ; Gelderblom, Hans, MD ; Hohenberger, Peter, Prof ; Leahy, Michael, FRCP ; von Mehren, Margaret, Prof ; Joensuu, Heikki, Prof ; Badalamenti, Giuseppe, MD ; Blackstein, Martin, FRCP ; Le Cesne, Axel, MD ; Schöffski, Patrick, Prof ; Maki, Robert G, Prof ; Bauer, Sebastian, MD ; Nguyen, Binh Bui, MD ; Xu, Jianming, MD ; Nishida, Toshirou, MD ; Chung, John, MD ; Kappeler, Christian, PhD ; Kuss, Iris, MD ; Laurent, Dirk, MD ; Casali, Paolo G, MD

The Lancet (British edition), 2013-01, Vol.381 (9863), p.295-302 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível